US Stock MarketDetailed Quotes

RDY Dr. Reddy's Laboratories

Watchlist
  • 13.600
  • -0.390-2.79%
Close Feb 14 16:00 ET
  • 13.560
  • -0.040-0.29%
Post 20:01 ET
11.33BMarket Cap18.30P/E (TTM)

Dr. Reddy's Laboratories Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
39.75%6.62B
-48.03%9.32B
-24.48%8.5B
-22.83%45.43B
-41.46%11.52B
-79.63%4.74B
93.15%17.93B
69.05%11.25B
109.46%58.88B
3,218.55%19.68B
Net income from continuing operations
1.81%14.04B
-9.36%13.42B
-0.75%13.92B
23.56%55.68B
36.26%13.07B
10.57%13.79B
33.00%14.8B
18.10%14.03B
91.22%45.07B
996.23%9.59B
Operating gains losses
-675.17%-1.65B
79.98%-221M
126.61%161M
-43.60%-1.58B
60.50%-158M
250.53%286M
-135.23%-1.1B
83.40%-605M
57.46%-1.1B
14.89%-400M
Depreciation and amortization
25.17%4.72B
4.91%3.98B
6.75%3.81B
17.45%14.84B
16.43%3.71B
15.26%3.77B
21.21%3.79B
17.02%3.57B
6.87%12.64B
7.81%3.19B
Deferred tax
5.28%4.7B
32.72%5.75B
10.43%4.9B
5.79%16.19B
-19.57%2.95B
15.30%4.47B
-13.02%4.33B
59.70%4.44B
75.26%15.3B
127.80%3.66B
Other non cash items
160.32%114M
125.14%92M
-447.62%-146M
-328.63%-567M
55.00%-54M
-230.34%-189M
-493.55%-366M
-67.69%42M
3,642.86%248M
-101.40%-120M
Change In working capital
18.62%-9.65B
-398.35%-7.78B
-60.77%-13.14B
-156.93%-20.18B
-142.05%-2.76B
-354.13%-11.86B
123.12%2.61B
-4.77%-8.17B
57.54%-7.86B
144.81%6.57B
-Change in receivables
11.04%-7.85B
-146.29%-3.4B
83.09%-786M
-40.02%-8.05B
-177.11%-1.92B
-561.61%-8.83B
297.68%7.34B
27.83%-4.65B
66.19%-5.75B
159.98%2.49B
-Change in inventory
79.65%-1.06B
-6.51%-5.01B
-36.33%-6.32B
-594.99%-18.45B
-3,124.79%-3.9B
-216.68%-5.2B
-471.70%-4.7B
-115.22%-4.64B
73.22%-2.65B
99.15%-121M
-Change in payables and accrued expense
-441.54%-1.33B
-32.47%1.58B
11.47%2.48B
14,943.48%3.46B
-290.10%-1.5B
-85.88%390M
228.65%2.34B
516.48%2.22B
-99.48%23M
-138.59%-384M
-Change in other working capital
-66.65%595M
59.35%-963M
-664.69%-8.51B
441.10%2.86B
-0.72%4.56B
9.25%1.78B
66.25%-2.37B
-183.94%-1.11B
-86.85%528M
72.16%4.59B
Cash from discontinued investing activities
Operating cash flow
39.75%6.62B
-48.03%9.32B
-24.48%8.5B
-22.83%45.43B
-41.46%11.52B
-79.63%4.74B
93.15%17.93B
69.05%11.25B
109.46%58.88B
115.80%19.68B
Investing cash flow
Cash flow from continuing investing activities
66.27%-5.46B
-322.21%-19.07B
-145.85%-20.25B
2.63%-40.28B
28.04%-11.35B
38.74%-16.18B
-178.79%-4.52B
-67.30%-8.24B
-56.79%-41.37B
28.27%-15.77B
Net PPE purchase and sale
-113.92%-7.09B
-127.77%-7.33B
-35.64%-4.91B
-36.46%-15.34B
54.05%-5.19B
-41,500.00%-3.31B
-2,354.96%-3.22B
-2,122.35%-3.62B
21.34%-11.24B
21.99%-11.3B
Net intangibles purchase and sale
-34.58%-1.62B
119.66%46M
84.60%-1.31B
-45.98%-11.01B
86.23%-1.04B
---1.21B
---234M
---8.53B
-422.73%-7.54B
-71.86%-7.54B
Net business purchase and sale
--0
----
----
---12M
--0
---12M
----
----
--0
--0
Net investment purchase and sale
118.58%2.22B
2,338.67%39.13B
-507.03%-14.47B
32.79%-15.7B
54.80%-5.55B
49.05%-11.96B
-119.68%-1.75B
1.43%3.56B
-108.61%-23.37B
31.87%-12.27B
Cash from discontinued investing activities
Investing cash flow
66.27%-5.46B
-322.21%-19.07B
-145.85%-20.25B
2.63%-40.28B
28.04%-11.35B
38.74%-16.18B
-178.79%-4.52B
-67.30%-8.24B
-56.79%-41.37B
28.27%-15.77B
Financing cash flow
Cash flow from continuing financing activities
-88.83%590M
329.53%16.15B
746.41%9.54B
85.99%-3.76B
87.60%-533M
806.00%5.28B
43.01%-7.04B
86.33%-1.48B
-1,009.04%-26.86B
-184.32%-4.3B
Net issuance payments of debt
-73.84%1.52B
2,920.27%16.56B
1,135.92%10.27B
121.31%4.35B
102.64%109M
431.54%5.82B
91.70%-587M
90.37%-991M
-845.78%-20.4B
-176.45%-4.13B
Net common stock issuance
177.78%25M
948.69%7.19B
-75.95%19M
118.75%805M
-85.97%31M
-88.89%9M
1,860.00%686M
154.84%79M
10.18%368M
2,662.50%221M
Cash dividends paid
--0
-0.21%-6.66B
--0
-33.52%-6.65B
--0
--0
-33.52%-6.65B
--0
-20.09%-4.98B
--0
Cash from discontinued financing activities
Financing cash flow
-88.83%590M
329.53%16.15B
746.41%9.54B
85.99%-3.76B
87.60%-533M
806.00%5.28B
43.01%-7.04B
86.33%-1.48B
-1,009.04%-26.86B
-184.32%-4.3B
Net cash flow
Beginning cash position
-16.62%11.29B
-32.03%4.91B
22.98%7.11B
-61.09%5.78B
20.39%7.54B
48.85%13.54B
14.78%7.23B
-61.09%5.78B
0.22%14.85B
-71.52%6.26B
Current changes in cash
128.44%1.75B
0.35%6.4B
-243.76%-2.21B
114.82%1.39B
7.40%-363M
-140.01%-6.16B
138.87%6.37B
116.96%1.54B
-1,235.09%-9.36B
94.96%-392M
Effect of exchange rate changes
-103.11%-5M
65.15%-23M
119.10%17M
-120.63%-59M
26.14%-65M
160.30%161M
-151.56%-66M
-117.35%-89M
-60.98%286M
-113.58%-88M
End cash Position
72.95%13.03B
-16.62%11.29B
-32.03%4.91B
22.98%7.11B
22.98%7.11B
20.39%7.54B
48.85%13.54B
14.78%7.23B
-61.09%5.78B
-61.09%5.78B
Free cash flow
-620.98%-2.2B
-89.94%1.41B
324.97%2.07B
-55.02%18B
-67.13%5.24B
-101.51%-305M
135.00%13.99B
54.74%-921M
341.65%40.01B
212.86%15.93B
Currency Unit
INR
INR
INR
INR
INR
INR
INR
INR
INR
INR
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Dec 31, 2024(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 39.75%6.62B-48.03%9.32B-24.48%8.5B-22.83%45.43B-41.46%11.52B-79.63%4.74B93.15%17.93B69.05%11.25B109.46%58.88B3,218.55%19.68B
Net income from continuing operations 1.81%14.04B-9.36%13.42B-0.75%13.92B23.56%55.68B36.26%13.07B10.57%13.79B33.00%14.8B18.10%14.03B91.22%45.07B996.23%9.59B
Operating gains losses -675.17%-1.65B79.98%-221M126.61%161M-43.60%-1.58B60.50%-158M250.53%286M-135.23%-1.1B83.40%-605M57.46%-1.1B14.89%-400M
Depreciation and amortization 25.17%4.72B4.91%3.98B6.75%3.81B17.45%14.84B16.43%3.71B15.26%3.77B21.21%3.79B17.02%3.57B6.87%12.64B7.81%3.19B
Deferred tax 5.28%4.7B32.72%5.75B10.43%4.9B5.79%16.19B-19.57%2.95B15.30%4.47B-13.02%4.33B59.70%4.44B75.26%15.3B127.80%3.66B
Other non cash items 160.32%114M125.14%92M-447.62%-146M-328.63%-567M55.00%-54M-230.34%-189M-493.55%-366M-67.69%42M3,642.86%248M-101.40%-120M
Change In working capital 18.62%-9.65B-398.35%-7.78B-60.77%-13.14B-156.93%-20.18B-142.05%-2.76B-354.13%-11.86B123.12%2.61B-4.77%-8.17B57.54%-7.86B144.81%6.57B
-Change in receivables 11.04%-7.85B-146.29%-3.4B83.09%-786M-40.02%-8.05B-177.11%-1.92B-561.61%-8.83B297.68%7.34B27.83%-4.65B66.19%-5.75B159.98%2.49B
-Change in inventory 79.65%-1.06B-6.51%-5.01B-36.33%-6.32B-594.99%-18.45B-3,124.79%-3.9B-216.68%-5.2B-471.70%-4.7B-115.22%-4.64B73.22%-2.65B99.15%-121M
-Change in payables and accrued expense -441.54%-1.33B-32.47%1.58B11.47%2.48B14,943.48%3.46B-290.10%-1.5B-85.88%390M228.65%2.34B516.48%2.22B-99.48%23M-138.59%-384M
-Change in other working capital -66.65%595M59.35%-963M-664.69%-8.51B441.10%2.86B-0.72%4.56B9.25%1.78B66.25%-2.37B-183.94%-1.11B-86.85%528M72.16%4.59B
Cash from discontinued investing activities
Operating cash flow 39.75%6.62B-48.03%9.32B-24.48%8.5B-22.83%45.43B-41.46%11.52B-79.63%4.74B93.15%17.93B69.05%11.25B109.46%58.88B115.80%19.68B
Investing cash flow
Cash flow from continuing investing activities 66.27%-5.46B-322.21%-19.07B-145.85%-20.25B2.63%-40.28B28.04%-11.35B38.74%-16.18B-178.79%-4.52B-67.30%-8.24B-56.79%-41.37B28.27%-15.77B
Net PPE purchase and sale -113.92%-7.09B-127.77%-7.33B-35.64%-4.91B-36.46%-15.34B54.05%-5.19B-41,500.00%-3.31B-2,354.96%-3.22B-2,122.35%-3.62B21.34%-11.24B21.99%-11.3B
Net intangibles purchase and sale -34.58%-1.62B119.66%46M84.60%-1.31B-45.98%-11.01B86.23%-1.04B---1.21B---234M---8.53B-422.73%-7.54B-71.86%-7.54B
Net business purchase and sale --0-----------12M--0---12M----------0--0
Net investment purchase and sale 118.58%2.22B2,338.67%39.13B-507.03%-14.47B32.79%-15.7B54.80%-5.55B49.05%-11.96B-119.68%-1.75B1.43%3.56B-108.61%-23.37B31.87%-12.27B
Cash from discontinued investing activities
Investing cash flow 66.27%-5.46B-322.21%-19.07B-145.85%-20.25B2.63%-40.28B28.04%-11.35B38.74%-16.18B-178.79%-4.52B-67.30%-8.24B-56.79%-41.37B28.27%-15.77B
Financing cash flow
Cash flow from continuing financing activities -88.83%590M329.53%16.15B746.41%9.54B85.99%-3.76B87.60%-533M806.00%5.28B43.01%-7.04B86.33%-1.48B-1,009.04%-26.86B-184.32%-4.3B
Net issuance payments of debt -73.84%1.52B2,920.27%16.56B1,135.92%10.27B121.31%4.35B102.64%109M431.54%5.82B91.70%-587M90.37%-991M-845.78%-20.4B-176.45%-4.13B
Net common stock issuance 177.78%25M948.69%7.19B-75.95%19M118.75%805M-85.97%31M-88.89%9M1,860.00%686M154.84%79M10.18%368M2,662.50%221M
Cash dividends paid --0-0.21%-6.66B--0-33.52%-6.65B--0--0-33.52%-6.65B--0-20.09%-4.98B--0
Cash from discontinued financing activities
Financing cash flow -88.83%590M329.53%16.15B746.41%9.54B85.99%-3.76B87.60%-533M806.00%5.28B43.01%-7.04B86.33%-1.48B-1,009.04%-26.86B-184.32%-4.3B
Net cash flow
Beginning cash position -16.62%11.29B-32.03%4.91B22.98%7.11B-61.09%5.78B20.39%7.54B48.85%13.54B14.78%7.23B-61.09%5.78B0.22%14.85B-71.52%6.26B
Current changes in cash 128.44%1.75B0.35%6.4B-243.76%-2.21B114.82%1.39B7.40%-363M-140.01%-6.16B138.87%6.37B116.96%1.54B-1,235.09%-9.36B94.96%-392M
Effect of exchange rate changes -103.11%-5M65.15%-23M119.10%17M-120.63%-59M26.14%-65M160.30%161M-151.56%-66M-117.35%-89M-60.98%286M-113.58%-88M
End cash Position 72.95%13.03B-16.62%11.29B-32.03%4.91B22.98%7.11B22.98%7.11B20.39%7.54B48.85%13.54B14.78%7.23B-61.09%5.78B-61.09%5.78B
Free cash flow -620.98%-2.2B-89.94%1.41B324.97%2.07B-55.02%18B-67.13%5.24B-101.51%-305M135.00%13.99B54.74%-921M341.65%40.01B212.86%15.93B
Currency Unit INRINRINRINRINRINRINRINRINRINR
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
XINGANJIANG
873167
+30.00%
INNOVATIVE DATA
835305
+29.98%
CHENGUANG MEDICAL
430300
+29.96%
4
Hangzhou Gaoxin Materials Technology
300478
+20.04%
5
Beijing Philisense Technology
300287
+20.03%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call